Artificial intelligence (AI) may hold the answers to some of the biggest challenges in optometry, according to Nahida Akter, PhD; Jack Phu, OD, PhD, FAAO; and Christopher Clark, OD, PhD, at the 2019 American Academy of Optometry meeting i
Halting glaucoma progression can be challenging, but as it turns out, medication is not the only tool in an OD’s toolbox. Many factors influence glaucoma progression in patients, some of which may be unrelated to the disease itself.
Eye care is an ever-evolving field, and 2019 brought with it several advances in approach and technique that surgeons need to keep in mind as they adopt the latest best practices in glaucoma surgery.
Over this past summer, I was fortunate enough to be given the opportunity to deliver a speech to the State University of New York (SUNY) College of Optometry residency class of 2019.
Whenever I deem a case of viral conjunctivitis to be significant enough to warrant the prescription of a topical steroid, I have a very brief discussion with the patient beforehand.
The task of diagnosing normal-tension glaucoma can be challenging and illusive. I have debated (and ultimately argued for) its very existence in lecture presentations.
Every three months, I have the opportunity to see a patient who goes way back in the lexicon of our practice. My grandfather stopped practicing about 30 years ago, and he saw this patient in the 1950s.
Surgeon sheds light on his experiences with variety of innovative surgery options
Myopia is expected to become a leading cause of permanent blindness around the world.1
Myopia is a disease—not a refractive error anymore, says Pamela Lowe, OD, FAAO, at Vision Expo East in New York City.